Sigue la actividad de operaciones con información privilegiada más reciente de Processa Pharmaceuticals. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Processa Pharmaceuticals.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
Los expertos no han informado de compras ni ventas en los últimos 30 días.
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Jan 31, 2025 | — | 12.40K | $0.80 | $9.89K | BUY | 331.82% | 16.14K | Jan 27 | ||
Jan 29, 2025 | CHIEF EXECUTIVE OFFICER | 87.20K | $0.80 | $69.54K | BUY | 436.00% | 107.20K | Jan 27 | ||
Jan 29, 2025 | PRES. RESEARCH & DEVELOPMENT | 124.50K | $0.80 | $99.29K | BUY | 125.19% | 223.95K | Jan 27 | ||
Jan 29, 2025 | CHIEF BUSINESS - STRATEGY OFF | 43.50K | $0.80 | $34.69K | BUY | 149.70% | 72.56K | Jan 27 | ||
Feb 08, 2024 | PRES. RESEARCH & DEVELOPMENT | 21.00K | $2.45 | $51.53K | BUY | 27.30% | 97.93K | Feb 07 | ||
Feb 07, 2024 | PRES. RESEARCH & DEVELOPMENT | 20.00K | $2.53 | $50.50K | BUY | 35.13% | 76.93K | Feb 06 | ||
Feb 01, 2024 | CHIEF BUSINESS - STRATEGY OFF | 4.00K | $2.38 | $9.53K | BUY | 17.04% | 27.48K | Jan 31 - Feb 01 | ||
Jan 31, 2024 | CHIEF EXECUTIVE OFFICER | 10.00K | $2.70 | $27.00K | BUY | 100.00% | 20.00K | Jan 30 | ||
Jan 31, 2024 | — | 8.00K | $2.69 | $21.54K | BUY | 29.66% | 34.97K | Jan 30 | ||
Jun 12, 2023 | PRESIDENT & CEO | 40.00K | $0.80 | $32.00K | BUY | 4.99% | 841.31K | Jun 12 | ||
Apr 14, 2023 | PRESIDENT & CEO | 20.00K | $0.55 | $11.00K | BUY | 2.56% | 801.31K | Apr 14 | ||
Apr 13, 2023 | PRESIDENT & CEO | 60.00K | $0.48 | $29.00K | BUY | 8.32% | 781.31K | Apr 11 - Apr 13 | ||
May 19, 2022 | CHIEF BUSINESS - STRATEGY OFF | 2.00K | $1.59 | $3.19K | BUY | 0.46% | 433.39K | May 17 | ||
Apr 08, 2022 | CHIEF BUSINESS - STRATEGY OFF | 2.00K | $3.29 | $6.59K | BUY | 0.47% | 431.39K | Apr 06 - Apr 07 | ||
Jan 31, 2022 | DIRECTOR | -1.85K | $3.30 | -$6.12K | SELL | -0.34% | 541.89K | Jan 27 | ||
Jan 04, 2022 | CHIEF BUSINESS - STRATEGY OFF | 3.00K | $4.00 | $12.00K | BUY | 0.70% | 429.39K | Dec 14 | ||
Dec 16, 2021 | CHIEF BUSINESS - STRATEGY OFF | 3.00K | $4.00 | $12.00K | BUY | 0.70% | 429.39K | Dec 14 | ||
Dec 07, 2021 | DIRECTOR | -9.70K | $4.78 | -$46.38K | SELL | -1.75% | 543.74K | Dec 03 - Dec 06 | ||
Dec 07, 2021 | CHIEF BUSINESS - STRATEGY OFF | 3.50K | $4.80 | $16.80K | BUY | 0.83% | 426.39K | Dec 03 | ||
Aug 30, 2021 | CHIEF BUSINESS - STRATEGY OFF | 4.00K | $6.02 | $24.09K | BUY | 0.95% | 422.89K | Aug 26 | ||
Jun 23, 2021 | CHIEF EXECUTIVE OFFICER | 10.00K | $7.67 | $76.72K | BUY | 2.56% | 400.45K | Jun 23 | ||
Jun 22, 2021 | CHIEF OPERATING OFFICER | 2.00K | $7.03 | $14.06K | BUY | 1.54% | 131.85K | Jun 22 | ||
Jun 22, 2021 | CHIEF BUSINESS - STRATEGY OFF | 2.00K | $6.65 | $13.30K | BUY | 0.50% | 401.74K | Jun 21 | ||
Jun 22, 2021 | CHIEF FINANCIAL OFFICER | 1.00K | $6.81 | $6.81K | BUY | 2.82% | 36.51K | Jun 21 | ||
Apr 15, 2021 | DIRECTOR | -16.20K | $9.60 | -$155.46K | SELL | -2.87% | 548.98K | Apr 13 - Apr 14 | ||
Apr 08, 2021 | — | -447.77K | $10.77 | -$4.82M | SELL | -29.83% | 1.05M | Apr 06 - Apr 08 | ||
Feb 22, 2021 | 10% OWNER | -28.93K | $11.49 | -$332.29K | SELL | -1.89% | 1.50M | Feb 18 - Feb 22 | ||
Oct 13, 2020 | — | 30.00K | $4.04 | $121.20K | PURCHASE | 2.00% | 1.53M | Oct 02 | ||
Oct 05, 2020 | — | 6.00K | $2.10 | $12.60K | PURCHASE | 14.55% | 47.25K | Oct 01 | ||
Oct 05, 2020 | — | 31.25K | $2.10 | $65.63K | PURCHASE | 8.48% | 399.74K | Oct 01 |
Explora operaciones con información privilegiada sobre todos los valores.